Endothelial function as a therapeutic target in coronary artery disease

N Sharma1, T C Andrews

  • 1Department of Medicine, Cardiovascular Division, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390-9034, USA.

Insights

Endothelial dysfunction is a key factor in cardiovascular disease development. Improving endothelial function through various interventions may be a crucial therapeutic strategy for coronary artery disease.

Area of Science:

  • Cardiovascular Science
  • Cell Biology
  • Medical Research

Background:

  • Endothelial cells are vital for vascular health, regulating tone, thrombosis, and cell interactions.
  • Endothelial dysfunction is implicated as a common pathway linking cardiovascular risk factors to atherosclerosis.
  • Cardiovascular risk factors negatively influence plaque development, progression, and rupture via endothelial dysfunction.

Purpose of the Study:

  • To highlight the role of endothelial dysfunction in cardiovascular disease.
  • To explore the connection between cardiovascular risk factors and endothelial dysfunction.
  • To discuss the therapeutic potential of improving endothelial function in coronary artery disease.

Main Methods:

  • Review of existing literature on endothelial function and cardiovascular disease.
  • Analysis of the impact of cardiovascular risk factors on endothelial cells.
  • Examination of interventions that affect endothelial function and cardiovascular risk.

Main Results:

  • Cardiovascular risk factors contribute to endothelial dysfunction, promoting atherosclerotic processes.
  • Numerous interventions reducing cardiovascular risk also enhance endothelial function.
  • Evidence suggests a strong link between endothelial health and overall cardiovascular well-being.

Conclusions:

  • Endothelial dysfunction represents a central mechanism in cardiovascular pathology.
  • Interventions targeting endothelial function show promise for managing coronary artery disease.
  • Restoring endothelial function is a potential therapeutic avenue for cardiovascular disease treatment.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...